Blockchain Registration Transaction Record
Carmed Pharmaceuticals Expands to US with Science-Driven Botanical Formulations
Carmed Pharmaceuticals expands to US with science-driven carvacrol formulations. Founder Mustafa Can leads company offering standardized botanical supplements for immune support and wellness.
This expansion matters because it represents a growing trend of evidence-based botanical supplements entering the mainstream wellness market, offering consumers alternatives that bridge traditional herbal knowledge with modern scientific validation. As more people seek preventive health solutions beyond conventional pharmaceuticals, Carmed's focus on standardized formulations with measurable mechanisms of action addresses concerns about supplement quality and consistency. The company's rigorous approach to research and GMP manufacturing could raise industry standards, potentially influencing how botanical products are developed and regulated. For consumers, this means access to more transparent, scientifically-vetted wellness options that prioritize reproducibility and quality control over marketing claims.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0x10eda9fa6a2f8f57714385baef93a41928aa94e72bf220eaef576bbb5ea0a9b7 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | glowU9Qx-1f04cc2b4151f17cade46b59c67370a7 |